KKR-owned Healthium, Temasek-backed Romsons in race to buy 70-80% stake in BL Lifesciences
KKR-owned Healthium Medtech and Temasek-backed Romsons Group are competing to acquire a 70-80% stake in BL Lifesciences, valued at ₹1,800-2,000 crore. KPMG is advising the promoters on this stake sale, which involves a family-owned business focused on medical devices for cardiac surgery and critical care. The outcome of this acquisition is expected to shape the medical devices market in India.